Olin (NYSE:OLN) Coverage Initiated by Analysts at KeyCorp

KeyCorp initiated coverage on shares of Olin (NYSE:OLN) in a report issued on Friday, Marketbeat Ratings reports. The firm set an “overweight” rating and a $26.00 price target on the specialty chemicals company’s stock. KeyCorp’s price target would indicate a potential upside of 50.51% from the stock’s previous close. KeyCorp also issued estimates for Olin’s Q3 2026 earnings at $0.06 EPS, Q4 2026 earnings at ($0.20) EPS and FY2028 earnings at $1.35 EPS.

Several other research analysts also recently weighed in on the stock. JPMorgan Chase & Co. reduced their price target on shares of Olin from $26.00 to $25.00 and set a “neutral” rating for the company in a research report on Thursday, June 18th. UBS Group reduced their price objective on Olin from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, August 3rd. Mizuho lifted their target price on shares of Olin from $23.00 to $24.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Wells Fargo & Company reiterated an “equal weight” rating and issued a $20.00 price objective (down from $25.00) on shares of Olin in a report on Monday, August 3rd. Finally, BMO Capital Markets lowered their price objective on Olin from $30.00 to $25.00 and set a “market perform” rating on the stock in a research note on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, ten have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat, Olin presently has a consensus rating of “Reduce” and an average price target of $22.62.

Olin Stock Down 1.1%

OLN opened at $17.27 on Friday. The company has a fifty day moving average of $19.57 and a two-hundred day moving average of $23.56. The stock has a market capitalization of $1.97 billion, a price-to-earnings ratio of -14.04 and a beta of 1.20. Olin has a fifty-two week low of $16.73 and a fifty-two week high of $30.46. The company has a debt-to-equity ratio of 1.77, a quick ratio of 0.87 and a current ratio of 1.42.

Olin (NYSE:OLN) last announced its quarterly earnings results on Thursday, July 30th. The specialty chemicals company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.25). The business had revenue of $1.74 billion during the quarter, compared to analysts’ expectations of $1.81 billion. Olin had a negative net margin of 2.08% and a negative return on equity of 4.76%. Olin’s revenue for the quarter was down .9% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.01) EPS. On average, research analysts expect that Olin will post -0.68 earnings per share for the current year.

Institutional Investors Weigh In On Olin

Large investors have recently bought and sold shares of the stock. Hotchkis & Wiley Capital Management LLC raised its position in shares of Olin by 5.5% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 12,690,488 shares of the specialty chemicals company’s stock worth $317,135,000 after acquiring an additional 661,730 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Olin by 22.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 5,627,997 shares of the specialty chemicals company’s stock worth $167,311,000 after acquiring an additional 1,031,498 shares in the last quarter. State Street Corp lifted its position in Olin by 1.1% in the second quarter. State Street Corp now owns 4,830,406 shares of the specialty chemicals company’s stock valued at $97,043,000 after acquiring an additional 50,309 shares during the last quarter. Pzena Investment Management LLC boosted its stake in Olin by 17.5% in the fourth quarter. Pzena Investment Management LLC now owns 4,507,913 shares of the specialty chemicals company’s stock valued at $93,900,000 after acquiring an additional 671,250 shares in the last quarter. Finally, Orbis Allan Gray Ltd boosted its stake in Olin by 448.9% in the fourth quarter. Orbis Allan Gray Ltd now owns 3,804,561 shares of the specialty chemicals company’s stock valued at $79,249,000 after acquiring an additional 3,111,393 shares in the last quarter. Hedge funds and other institutional investors own 88.67% of the company’s stock.

About Olin

Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.

In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.